Biochem/physiol Actions
Cell permeable: no
Reversible: no
Product does not compete with ATP.
Primary TargetInducible nitric oxide synthase
General description
Mutant of E. coli 0111:B4. Stimulates the activity of inducible nitric oxide synthase. Induces apoptosis in mouse thymus and swine lymphocytes. Highly purified preparation.
Mutant of E. coli O111: B4. Stimulates the activity of inducible nitric oxide synthase. Induces apoptosis in mouse thymus and swine lymphocytes.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Hattori, S., et al. 1995. Biochem. Mol. Biol. Int.35, 177.Mayeux, P.R., et al. 1995. Biochem. Pharmacol.49, 115.Norimatsu, M., et al. 1995. Infect. Immun.63, 1122.Feinstein, D.L., et al. 1993. J. Neurochem.60, 1945.Zhang, Y.H., et al. 1993. Infect. Immun.61, 5044.
Packaging
5 mg in Plastic ampoule
Preparation Note
LPS will form a suspension in H2O; slight warming and vortexing may be required to achieve complete dispersion in H2O. Addition of 0.5% triethylamine will also help with dispersion; triethylamine is very basic and can be neutralized with Trix-HCl to avoid hydrolysis of the fatty acid chains.
Reconstitution
Following reconstitution refrigerate (4°C). Stock solutions are stable for up to 1 year at 4°C.
Warning
Toxicity: Harmful (C)
This product has met the following criteria to qualify for the following awards: